Cargando…

Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report

Mantle cell lymphoma (MCL) is a rare subtype of B-cell lymphoma that can present in a variety of ways, including the leukemic phase, where it can occasionally be mistaken for acute leukemia due to the unusually high or rapidly growing number of leukocytes and the presence of circulating cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaati, Alshaimaa M, Alasiri, Meshal M, Alansari, Bayan A, Mulla, Wed Y, Al-Marzouki, Adel F, Daous, Yara M, Radhwi, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806947/
https://www.ncbi.nlm.nih.gov/pubmed/36601362
http://dx.doi.org/10.7759/cureus.33239
_version_ 1784862619956412416
author Alsaati, Alshaimaa M
Alasiri, Meshal M
Alansari, Bayan A
Mulla, Wed Y
Al-Marzouki, Adel F
Daous, Yara M
Radhwi, Osman
author_facet Alsaati, Alshaimaa M
Alasiri, Meshal M
Alansari, Bayan A
Mulla, Wed Y
Al-Marzouki, Adel F
Daous, Yara M
Radhwi, Osman
author_sort Alsaati, Alshaimaa M
collection PubMed
description Mantle cell lymphoma (MCL) is a rare subtype of B-cell lymphoma that can present in a variety of ways, including the leukemic phase, where it can occasionally be mistaken for acute leukemia due to the unusually high or rapidly growing number of leukocytes and the presence of circulating cancer cells that are morphologically similar to leukemic blasts in myeloid or acute lymphoblastic leukemia. We present the case of an 83-year-old Yemeni woman with multiple comorbidities who presented with abdominal pain and constitutional symptoms. She was found to have diffuse lymphadenopathy on clinical and radiological assessments. Her white blood cell count at presentation was 221 × 10(9)/L with marked monocytosis (72.8%). Lymph node biopsy and bone marrow studies, including CCND1/IGH molecular studies, confirmed MCL, the pleomorphic subtype. The patient was deemed unfit for standard-of-care chemotherapy and was started on single-agent rituximab with a slow introduction to ibrutinib but succumbed to death after two weeks of ibrutinib 280 mg daily. This case serves as a reminder to keep an open mind and take into account atypical disease presentations when formulating differential diagnoses to prevent late diagnosis and any unnecessary intervention that can postpone appropriate therapy.
format Online
Article
Text
id pubmed-9806947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-98069472023-01-03 Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report Alsaati, Alshaimaa M Alasiri, Meshal M Alansari, Bayan A Mulla, Wed Y Al-Marzouki, Adel F Daous, Yara M Radhwi, Osman Cureus Pathology Mantle cell lymphoma (MCL) is a rare subtype of B-cell lymphoma that can present in a variety of ways, including the leukemic phase, where it can occasionally be mistaken for acute leukemia due to the unusually high or rapidly growing number of leukocytes and the presence of circulating cancer cells that are morphologically similar to leukemic blasts in myeloid or acute lymphoblastic leukemia. We present the case of an 83-year-old Yemeni woman with multiple comorbidities who presented with abdominal pain and constitutional symptoms. She was found to have diffuse lymphadenopathy on clinical and radiological assessments. Her white blood cell count at presentation was 221 × 10(9)/L with marked monocytosis (72.8%). Lymph node biopsy and bone marrow studies, including CCND1/IGH molecular studies, confirmed MCL, the pleomorphic subtype. The patient was deemed unfit for standard-of-care chemotherapy and was started on single-agent rituximab with a slow introduction to ibrutinib but succumbed to death after two weeks of ibrutinib 280 mg daily. This case serves as a reminder to keep an open mind and take into account atypical disease presentations when formulating differential diagnoses to prevent late diagnosis and any unnecessary intervention that can postpone appropriate therapy. Cureus 2023-01-02 /pmc/articles/PMC9806947/ /pubmed/36601362 http://dx.doi.org/10.7759/cureus.33239 Text en Copyright © 2023, Alsaati et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pathology
Alsaati, Alshaimaa M
Alasiri, Meshal M
Alansari, Bayan A
Mulla, Wed Y
Al-Marzouki, Adel F
Daous, Yara M
Radhwi, Osman
Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report
title Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report
title_full Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report
title_fullStr Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report
title_full_unstemmed Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report
title_short Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report
title_sort unusual presentation of leukemic-phase mantle cell lymphoma: a case report
topic Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806947/
https://www.ncbi.nlm.nih.gov/pubmed/36601362
http://dx.doi.org/10.7759/cureus.33239
work_keys_str_mv AT alsaatialshaimaam unusualpresentationofleukemicphasemantlecelllymphomaacasereport
AT alasirimeshalm unusualpresentationofleukemicphasemantlecelllymphomaacasereport
AT alansaribayana unusualpresentationofleukemicphasemantlecelllymphomaacasereport
AT mullawedy unusualpresentationofleukemicphasemantlecelllymphomaacasereport
AT almarzoukiadelf unusualpresentationofleukemicphasemantlecelllymphomaacasereport
AT daousyaram unusualpresentationofleukemicphasemantlecelllymphomaacasereport
AT radhwiosman unusualpresentationofleukemicphasemantlecelllymphomaacasereport